Compounds that are mammalian metabolites of an agonist of G-protein-coupled receptor 1.39 (GPR139), intermediates used in the synthesis of such metabolites, pharmaceutical compositions comprising such metabolites, and the use of such metabolites as biomarkers and agents in the treatment of schizophrenia, for example, negative and/or cognitive symptoms of schizophrenia, disorders associated with social and cognitive dysfunction, as well as several other disorders related to modulated of GPR139.

Compounds that are mammalian metabolites of an agonist of G-protein-coupled receptor 1.39 (GPR139), intermediates used in the synthesis of such metabolites, pharmaceutical compositions comprising such metabolites, and the use of such metabolites as biomarkers and agents in the treatment of schizophrenia, for example, negative and/or cognitive symptoms of schizophrenia, disorders associated with social and cognitive dysfunction, as well as several other disorders related to modulated of GPR139.

The disclosure relates to compounds of formula I which are useful as kinase modulators including RIPK 1 modulation. The disclosure also provides methods of making and using the compounds for example in treatments related to necrosis or inflammation as well as other indications. ##STR00001##

Provided are imaging agents comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and methods of their use.

##STR00001##

Provided are imaging agents comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and methods of their use.

##STR00001##

In one aspect, the invention relates to triazol-1-ol compounds, analogs thereof, compositions comprising same, and methods of using same, alone or in combination with other agents, to reactivate latent retroviruses, and more particularly to reactivate latent HIV-1. Such compounds, compositions, and methods can be used, for example, in connection with diagnosing and/or treating a retrovirus, and more specifically HIV-1. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

In one aspect, the invention relates to triazol-1-ol compounds, analogs thereof, compositions comprising same, and methods of using same, alone or in combination with other agents, to reactivate latent retroviruses, and more particularly to reactivate latent HIV-1. Such compounds, compositions, and methods can be used, for example, in connection with diagnosing and/or treating a retrovirus, and more specifically HIV-1. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

The present invention discloses a compound, which comprises the structure shown in FIG. 1; and further discloses a preparation method thereof, a precursor material used in the preparation method, explosives comprising the compound, and the application thereof in the field of explosives, in particular in the application of green environmentally-friendly primers. The compound disclosed by the invention may provide green environmental protection type primer, and meets the problem of requiring green environmental protection primers in many fields such as military industry, firework and civil explosion engineering. The compound disclosed in the invention has a simple preparation method and may be prepared by simple reaction steps and conditions, which has the advantages of being green and reliable as no pollution during the reaction process and use, no metal required in the compound structure, with good stability, high impact sensitivity, friction sensitivity, and initiation capability, and appropriate minimum initiating charge.

The present invention discloses a compound, which comprises the structure shown in FIG. 1; and further discloses a preparation method thereof, a precursor material used in the preparation method, explosives comprising the compound, and the application thereof in the field of explosives, in particular in the application of green environmentally-friendly primers. The compound disclosed by the invention may provide green environmental protection type primer, and meets the problem of requiring green environmental protection primers in many fields such as military industry, firework and civil explosion engineering. The compound disclosed in the invention has a simple preparation method and may be prepared by simple reaction steps and conditions, which has the advantages of being green and reliable as no pollution during the reaction process and use, no metal required in the compound structure, with good stability, high impact sensitivity, friction sensitivity, and initiation capability, and appropriate minimum initiating charge.

The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.